EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, OASMY: Vivesto Ab

21 Nov 2025
LAST:

0.0100

CHANGE:
 0.00		OPEN:
0.0100		HIGH:
0.0100		ASK:
0.0000		VOLUME:
100
CHG(%):
0.00		PREV:
0.0100		LOW:
0.0100		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Nov 250.01000.01000.01000.0100100

PROFILE

Name:Vivesto Ab
About:Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Sector:Healthcare
Address:Gustav III:s Boulevard 46, Solna, Sweden, 169 73
Website:https://www.vivesto.com
CIK:0001607245
ISIN:US67421W1099
FIGI:BBG009SYD7H7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.0120.0%
MA10:0.0280.0%
Week High:0.010.0%
Week Low:0.010.0%